Novartis: Pluvicto zeigt Vorteile bei früherem Einsatz vor Chemotherapie

Pharma - Novartis hat neue US-Studien vorgestellt, die den Nutzen von Pluvicto bei metastasiertem, kastrationsresistentem Prostatakrebs vor einer Chemotherapie belegen.


2 w.
Science
ID: -2262846886203933281


Similar News expand_more


Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Military
Military
Military
Science
Science
Science
Science
Science
Military
Science
Science
Science
Politics
Military
Science
Military
Entertainment
Sport
Military
Sport
Science
Science
Science
Sport
Military
Military
Science
Science
Science
Military
Military
Military
Sport
Sport
Education
Military
Science
Military
Science
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down